Role of interleukin-6 in cachexia: therapeutic implications.
about
Skeletal muscle wasting and renewal: a pivotal role of myokine IL-6Effects of sex steroids on bones and muscles: Similarities, parallels, and putative interactions in health and diseaseLiver inflammation and metabolic signaling in ApcMin/+ mice: the role of cachexia progression.Xilonix, a novel true human antibody targeting the inflammatory cytokine interleukin-1 alpha, in non-small cell lung cancerSupplementation of Magnolol Attenuates Skeletal Muscle Atrophy in Bladder Cancer-Bearing Mice Undergoing Chemotherapy via Suppression of FoxO3 Activation and Induction of IGF-1.Eccentric contraction-induced myofiber growth in tumor-bearing mice.Combination of exercise training and erythropoietin prevents cancer-induced muscle alterationsIdentification of neutrophil-derived proteases and angiotensin II as biomarkers of cancer cachexiaSTAT3 in the systemic inflammation of cancer cachexia.The emerging role of skeletal muscle oxidative metabolism as a biological target and cellular regulator of cancer-induced muscle wastingThe MEK-Inhibitor Selumetinib Attenuates Tumor Growth and Reduces IL-6 Expression but Does Not Protect against Muscle Wasting in Lewis Lung Cancer Cachexia.Short-term pyrrolidine dithiocarbamate administration attenuates cachexia-induced alterations to muscle and liver in ApcMin/+ mice.Loss of MTSS1 results in increased metastatic potential in pancreatic cancer.Ecology meets cancer biology: the cancer swamp promotes the lethal cancer phenotype.Muscle wasting as main evidence of energy impairment in cancer cachexia: future therapeutic approaches.Brucea javanica oil emulsion alleviates cachexia induced by Lewis lung cancer cells in mice.Molecular Pathways: Cachexia Signaling-A Targeted Approach to Cancer Treatment.Smad7 gene delivery prevents muscle wasting associated with cancer cachexia in mice.Disrupted Skeletal Muscle Mitochondrial Dynamics, Mitophagy, and Biogenesis during Cancer Cachexia: A Role for Inflammation.Epigenetic targeting of bromodomain protein BRD4 counteracts cancer cachexia and prolongs survival.The Role of gp130 in Basal and Exercise Trained Skeletal Muscle Mitochondrial Quality Control.Protein Turnover and Metabolism in the Elderly Intensive Care Unit Patient.Protein Requirements in Critically Ill Older Adults.Metabolic Alterations in a Slow-Paced Model of Pancreatic Cancer-Induced Wasting.Increased gut permeability in cancer cachexia: mechanisms and clinical relevance.PGC-1α4 gene expression is suppressed by the IL-6-MEK-ERK 1/2 MAPK signalling axis and altered by resistance exercise, obesity and muscle injury.eIF4A inhibition prevents the onset of cytokine-induced muscle wasting by blocking the STAT3 and iNOS pathways.Anti-cachectic effect of Antrodia cinnamomea extract in lung tumor-bearing mice under chemotherapy.Systematic literature review of IL-6 as a biomarker or treatment target in patients with gastric, bile duct, pancreatic and colorectal cancerEssential roles of mitochondrial and heme function in lung cancer bioenergetics and tumorigenesisMyokines as Possible Therapeutic Targets in Cancer Cachexia
P2860
Q26743557-C9AA2D01-E130-4EDF-BDFE-8FFAEA8B67DFQ28606560-5A9D1A5A-18B3-4208-8CE7-CC12EE665BE1Q35196068-BAFA2CFF-D68F-4750-8BF6-51E4AFA8B372Q35786634-D65A8C3E-9D24-4720-BCF3-3B385CEB5CC1Q35850891-62799590-3953-4579-AE50-378562ACB13AQ36422662-B517BA2D-3597-4CFD-83B4-CE5AEABB68B2Q36685366-CC5F78C0-FD83-4C7B-8E97-A05128A44764Q36707757-7A327771-F450-4EB6-84A4-A7C1709DC0BBQ36901910-6F449828-E983-4C73-A762-4DE70540EAC6Q36901945-3AFD9069-F217-412F-A6FB-9526E4D88626Q37590551-28A23D2B-7047-48DE-9AAA-13406EE1AAEBQ37644886-9A5BFA48-8B26-4A6A-8C39-6D10176FD9E2Q37725460-A4262FAD-58DE-4820-A6AF-0AC6EF5643C2Q38430999-BCE8440E-9ED6-4AD4-A190-B9EFB554C802Q38587970-A9DF352C-9881-4295-A710-EF03C80DE47EQ38682214-3EEAA8D5-CDAB-40F0-BBDA-928D6441EA08Q38875788-E2C97EDA-8484-460E-AA37-4E9EA9B8C4DCQ40640594-E4427FE2-8C0C-4F5D-A6F3-F48DF3549003Q41146515-E8679CEC-10E4-46E6-A393-392DF6B76E19Q47095769-EFEB85B8-8682-44FA-977A-1D4888D6AB68Q49495536-DD729157-FCB9-40E3-B7C8-5D1EFBA14BC8Q51067336-AE6C6C31-AC79-4782-A529-20A5E21E743BQ51761257-7933E380-9D61-4201-A5ED-126215177E9CQ52313109-C2029515-83FC-4AB1-88ED-60366063230BQ53688957-20E0C04C-77BC-4628-9725-EFB6EAD878DBQ53762601-27A51765-3361-457D-A180-7FE3F3EA19FDQ54959711-B4548B78-218A-4F75-BE4E-0191E6661290Q55346140-C06BD201-1BD5-4080-8675-4DFA297AFFAAQ57115352-433B9E28-DD2F-4DFF-AF49-8AE921E1F760Q58615775-1891E45F-2AC2-4422-8D10-18A7BC74A00DQ58694027-446B15EF-99FA-45AD-A871-A60335FAD5E0
P2860
Role of interleukin-6 in cachexia: therapeutic implications.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh
2014年學術文章
@zh-hant
name
Role of interleukin-6 in cachexia: therapeutic implications.
@en
type
label
Role of interleukin-6 in cachexia: therapeutic implications.
@en
prefLabel
Role of interleukin-6 in cachexia: therapeutic implications.
@en
P2860
P1476
Role of interleukin-6 in cachexia: therapeutic implications.
@en
P2093
Aditi A Narsale
P2860
P304
P356
10.1097/SPC.0000000000000091
P577
2014-12-01T00:00:00Z